Palantir Technologies shares plunged Monday, extending losses following a report last week that the Trump administration directed the Pentagon to trim the U.S. defense budget.

The analysts downgraded Rivian stock to "underperform" from "neutral," and lowered their price target to $10 from $13. They noted a "generally soft" demand environment for EVs, and said shifting ...

The Federal Reserve's preferred measure of inflation likely decelerated in January, providing some reassurance that cost-of-living increases are slowing down to pre-pandemic levels.

Starbucks plans to lay off 1,100 corporate employees, CEO Brian Niccol said Monday, while also leaving several hundred open positions unfilled.

Even though Tesla shares are down this year on investor worries that CEO Elon Musk is too focused on the cost-cutting department DOGE, Wedbush stuck with its $550 price target and outperform call on ...

Small-cap stocks fell further into correction territory on Monday as equities continued to stumble amid heightened economic uncertainty.

Nike ( NKE) was the best-performing stock in the Dow and S&P 500 when Jefferies upgraded the stock and raised the price ...

Macroeconomic factors kept the mortgage market relatively low for much of 2021. In particular, the Federal Reserve had been buying billions of dollars of bonds in response to the pandemic's economic ...

Bridge Investment Group Holdings shares took off Monday as the real-estate investment firm agreed to be purchased by Apollo Global Management for $1.5 billion.

Sales of Owens Corning's legacy products slumped in the fourth quarter and the company warned of business headwinds ahead.

The public is getting impatient for President Donald Trump to fulfill his campaign promises to "end inflation," but it might be on its way down all on its own.

Summit Therapeutics shares are dropping Monday morning as it reported a fourth-quarter adjusted loss nearly double that of the prior year. It also announced a collaboration with Pfizer.